Trial Profile
Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Dec 2017
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Phenprocoumon
- Indications Stroke
- Focus Therapeutic Use
- Acronyms RELOAD
- Sponsors Bayer
- 30 Aug 2017 Results assessing characteristics of 15mg od rivaroxaban presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology
- 30 Aug 2017 Baseline charecteristics (n=33668) presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology
- 06 Mar 2017 Status changed from active, no longer recruiting to completed.